Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    9445407 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Protective Role of Oxcarbazepine in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Oxcarbazepine;   Drug: Placebo
2 Enrolling by invitation Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Domperidone

Study has passed its completion date and status has not been verified in more than two years.